IC51 / AEs / Results Immunogenicity Safety Demographic Subgroup / Prevnar / Intercell AG / Total / HAVRIX / Solicited AE / ITT / /
Continent
Europe / /
Country
Malaysia / United States / Australia / Philippines / India / /
Event
FDA Phase / /
IndustryTerm
treatment / non-endemic regions planning travel / treatment groups / age / healthy subjects planning travel / /
MedicalCondition
JE / Japanese Encephalitis Vaccine IC51 / Japanese Encephalitis / dengue virus / pre-existing dengue virus / /
MedicalTreatment
active immunization / vaccinations / Vaccination / /
Organization
Biostatistics and Epidemiology Division / DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Center / RPM CC / Biologics Evaluation and Research office of Biostatistics / /
Person
P.H. Branch / Tsai-Lien Lin / Mathematical Statistician / Richard Daemer / P.H. Estelle Russek-Cohen / A. Dale Horne / Doran Fink / Bharat Khurana / John Scott / Mridul K. Chowdhury / Christopher Egelebo / / /
Position
Mathematical Statistician / Team Leader / EXECUTIVE / Major / Chair / Chief / /
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Center for Biologics Evaluation and Research Office of Biostatistics and Epidemiology Division of Biostatistics